The University of Southampton
University of Southampton Institutional Repository

A neuropharmacological study of central dopamine receptors

A neuropharmacological study of central dopamine receptors
A neuropharmacological study of central dopamine receptors
The experiments in this thesis describe the actions of some novel dopamine agonists and antagonists on the neuronal activity of extrace 11u1ar1y recorded cells in the substantia nigra zona compacta in vivo and in vitro.

The dopamine agonists, apomorphine, piribedil, S-36O8, RU24213 and RU24926 all potently inhibited the neuronal activity of the substantia nigra neurones, when given intravenously. Piribedil and S-3608 were short acting agonists , whereas RU24213 and RU24926 were long a c t i n g , both with a two phase recovery. A second dose of either RU24213 and RU24926 or apomorphine produced a tachyphy1 actic effect, which reduced the inhibitory agonist responses.

The dibenzoyl ester of ADTN, synthesised as a soluble prodrug of ADTN, failed to have any dopaminergic agonist activity on the substantia nigra cells, when given intravenously, at extremely high doses.

In addition, when tested on the hyperactivity induced by dopamine agonists, directly injected I n t o the nucleus accumbens, S-36O8 and RU24213 did not induce any locomotor activity. While RU24926 produced a weak and short stimulation of locomotor activity compared with ADTN.

A newly proposed dopamine antagonist, zetidoline, given intravenously, antagonised the inhibitory effect of apomorphine whereas the dopamine antagonist, sulpiride, at very large doses, failed to antagonise apomorphine inhibitions. Applied iontophoretically, sulpiride and zetidoline antagonised the responses to iontophoretically applied dopamine and noradrenaline, but zetidoline did not affect the responses to the neurotransmitters, glutamate, GABA and glycine. On cerebellar neurones, sulpiride failed to antagonise the responses to dopamine and noradrenaline. Zetidoline applied iontophoretically was directly depressant on cerebellar neurones.

In the in vitro nigral brain slice, zetidoline was a competitive antagonist of the inhibitory actions of dopamine with a pAg of 7.0 2.

In contrast to its potent and selective activity in inhibiting dopamine
responses on substantia nigra neurones, zetidoline, in the ADTN-induced locomotor test for dopaminergic activity, was weakly active as an antagonist. Sulpiride, however, was a potent antagonist in this test .
University of Southampton
Harris, Noël Clifford
300a9394-3fd2-41e4-9f36-78a7fbe19da4
Harris, Noël Clifford
300a9394-3fd2-41e4-9f36-78a7fbe19da4
Woodruff, G.N.
1c1ad355-d508-43d2-a75a-3db2c7dd079b

Harris, Noël Clifford (1984) A neuropharmacological study of central dopamine receptors. University of Southampton, Doctoral Thesis, 207pp.

Record type: Thesis (Doctoral)

Abstract

The experiments in this thesis describe the actions of some novel dopamine agonists and antagonists on the neuronal activity of extrace 11u1ar1y recorded cells in the substantia nigra zona compacta in vivo and in vitro.

The dopamine agonists, apomorphine, piribedil, S-36O8, RU24213 and RU24926 all potently inhibited the neuronal activity of the substantia nigra neurones, when given intravenously. Piribedil and S-3608 were short acting agonists , whereas RU24213 and RU24926 were long a c t i n g , both with a two phase recovery. A second dose of either RU24213 and RU24926 or apomorphine produced a tachyphy1 actic effect, which reduced the inhibitory agonist responses.

The dibenzoyl ester of ADTN, synthesised as a soluble prodrug of ADTN, failed to have any dopaminergic agonist activity on the substantia nigra cells, when given intravenously, at extremely high doses.

In addition, when tested on the hyperactivity induced by dopamine agonists, directly injected I n t o the nucleus accumbens, S-36O8 and RU24213 did not induce any locomotor activity. While RU24926 produced a weak and short stimulation of locomotor activity compared with ADTN.

A newly proposed dopamine antagonist, zetidoline, given intravenously, antagonised the inhibitory effect of apomorphine whereas the dopamine antagonist, sulpiride, at very large doses, failed to antagonise apomorphine inhibitions. Applied iontophoretically, sulpiride and zetidoline antagonised the responses to iontophoretically applied dopamine and noradrenaline, but zetidoline did not affect the responses to the neurotransmitters, glutamate, GABA and glycine. On cerebellar neurones, sulpiride failed to antagonise the responses to dopamine and noradrenaline. Zetidoline applied iontophoretically was directly depressant on cerebellar neurones.

In the in vitro nigral brain slice, zetidoline was a competitive antagonist of the inhibitory actions of dopamine with a pAg of 7.0 2.

In contrast to its potent and selective activity in inhibiting dopamine
responses on substantia nigra neurones, zetidoline, in the ADTN-induced locomotor test for dopaminergic activity, was weakly active as an antagonist. Sulpiride, however, was a potent antagonist in this test .

Text
Harris - Version of Record
Available under License University of Southampton Thesis Licence.
Download (15MB)

More information

Published date: 1 June 1984

Identifiers

Local EPrints ID: 437727
URI: http://eprints.soton.ac.uk/id/eprint/437727
PURE UUID: 6d9ed91b-1bcd-489c-bb8e-dad71af8697f

Catalogue record

Date deposited: 13 Feb 2020 17:30
Last modified: 16 Mar 2024 06:38

Export record

Contributors

Author: Noël Clifford Harris
Thesis advisor: G.N. Woodruff

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×